Arianna Barbetta, Francisco Schlottmann, Tamar Nobel, David B Sewell, Meier Hsu, Kay See Tan, Hans Gerdes, Pari Shah, Manjit S Bains, Matthew Bott, James M Isbell, David R Jones, Daniela Molena
BACKGROUND: Induction therapy has not been proven to be beneficial for patients with clinical T2N0 esophageal adenocarcinoma. Surgery alone is associated with disappointing survival for patients found to have nodal disease on final pathologic examination. The aim of this study was to identify factors that predict pathologic nodal involvement in patients with endoscopic ultrasound (EUS)-proven T2N0 esophageal adenocarcinoma. METHODS: We retrospectively reviewed patients with EUS-staged T2N0 (uT2N0) esophageal adenocarcinoma treated with surgery alone...
April 5, 2018: Annals of Thoracic Surgery